BioArdis is an innovative therapeutic development company with a pipeline of oncology and immuno-oncology drug candidates, and a novel chimeric antigen receptor T cell (“CAR-T”) platform with multiple therapies targeting solid tumors.
View Top Employees from BioArdisWebsite | https://bioardis.com |
Revenue | $1 million |
Employees | 3 (2 on RocketReach) |
Founded | 2017 |
Address | 7310 Miramar Road Suite 500, San Diego, California 92126, US |
Phone | (858) 412-2027 |
Industry | Biotechnology Research, Business Services General, Drug Discovery, Business Services, Biotechnology |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies |
Looking for a particular BioArdis employee's phone or email?
The BioArdis annual revenue was $1 million in 2024.
Kedar Muley is the CEO of BioArdis.
2 people are employed at BioArdis.
BioArdis is based in San Diego, California.
The NAICS codes for BioArdis are [54171, 54, 541, 541713, 5417].
The SIC codes for BioArdis are [87, 873].